Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.215
+0.025 (1.14%)
Feb 26, 2026, 2:19 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 416.02 million as of February 25, 2026. Its market cap has decreased by -42.92% in one year.
Market Cap
416.02M
Enterprise Value
708.47M
Revenue
737.49M
Ranking
n/a
PE Ratio
15.54
Stock Price
2.22
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 416.02M, a decrease of -39.73%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 416.02M | -20.75% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 11.28B |
| Integral Diagnostics | 842.33M |
| Healius | 486.51M |
| Monash IVF Group | 272.74M |
| Rhythm Biosciences | 67.12M |
| Cryosite | 58.57M |
| Microba Life Sciences | 52.98M |
| INOVIQ | 49.98M |